Press Release

<< Back
Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2012 Financial Results

Menlo Park, Calif., March 5, 2013 - Geron Corporation (Nasdaq: GERN) will announce its financial results for the fourth quarter and year ended December 31, 2012, on Tuesday, March 12, 2013, after the market close. Geron's management will host a conference call for analysts and investors on Wednesday, March 13, 2013, at 9:00 a.m. Eastern Time to discuss the company's fourth quarter and annual results and highlights.

Participants can access the conference call live via telephone by dialing 866-270-6057 (U.S.); 617-213-8891 (international). The passcode is 80790305. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast is also available at The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through April 12, 2013.

About Geron

Geron is a biopharmaceutical company developing first-in-class therapies for cancer, including its telomerase inhibitor, imetelstat, in clinical development. For more information about Geron, visit


Anna Krassowska, Ph.D.
Investor and Media Relations


 Print Page |  E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts